310947160	310947160	CD	B-NP	O
|	|	NN	I-NP	O
BH	BH	NN	I-NP	O
|	|	NN	I-NP	O
61430183	61430183	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0245024	0245024	CD	B-NP	O
|	|	CC	I-NP	O
11/23/2006	11/23/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ATRIAL	ATRIAL	NNP	I-NP	I-protein
FIBRILLATION	FIBRILLATION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Unsigned	Unsigned	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/21/2006	10/21/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/26/2006	3/26/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
DYESS	DYESS	NNP	B-NP	O
,	,	,	O	O
DUANE	DUANE	NNP	B-NP	O
MD	MD	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
83-year-old	83-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
AFib	AFib	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
permanent	permanent	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
,	,	,	O	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
exertional	exertional	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
runs	run	NNS	B-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
.	.	.	O	O

Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
started	start	VBD	B-VP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
AFib	AFib	NN	B-NP	O
and	and	CC	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
worsened	worsen	VBD	B-VP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
began	begin	VBD	B-VP	O
sleeping	sleep	VBG	I-VP	O
upright	upright	RB	B-ADVP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
recliner	recliner	NN	I-NP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
any	any	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
radiating	radiate	VBG	B-VP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
decreased	decrease	VBN	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
daily	daily	JJ	B-NP	O
living	living	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
week	week	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
fatigue	fatigue	VB	I-VP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
August	August	NNP	B-NP	O
2001	2001	CD	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
two-vessel	two-vessel	JJ	I-NP	O
CABG	CABG	NN	I-NP	O
and	and	CC	I-NP	O
NSTEMI	NSTEMI	NN	I-NP	O
;	;	:	O	O
3/2	3/2	CD	B-NP	O
,	,	,	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
35	35	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
notable	notable	JJ	I-NP	O
for	for	IN	B-PP	O
mild	mild	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
dilatation	dilatation	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
with	with	IN	B-PP	O
hypokinesis	hypokinesis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
septum	septum	NN	I-NP	O
,	,	,	O	O
mid	mid	JJ	B-NP	O
inferior-posterior	inferior-posterior	JJ	I-NP	O
basal	basal	JJ	I-NP	O
septum	septum	NN	I-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
0.9	0.9	CD	B-NP	O
,	,	,	O	O
MR	MR	NN	B-NP	B-protein
,	,	,	O	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
TR	TR	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
PAP	PAP	NN	B-NP	B-protein
of	of	IN	B-PP	O
38	38	CD	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
;	;	:	O	O
hypertension	hypertension	NN	B-NP	O
;	;	:	O	O
AFib	AFib	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
;	;	:	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
permanent	permanent	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
;	;	:	O	O
anemia	anemia	NN	B-NP	O
;	;	:	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
bladder	bladder	NN	I-NP	O
resection	resection	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
cancer	cancer	NN	B-NP	O
;	;	:	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
;	;	:	O	O
aortic	aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
;	;	:	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
;	;	:	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	known	JJ	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Coumadin	Coumadin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
;	;	:	O	O
insulin	insulin	NN	B-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
units	unit	NNS	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
;	;	:	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
;	;	:	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
;	;	:	O	O
Levoxyl	Levoxyl	NN	B-NP	O
100	100	CD	I-NP	O
mcg	mcg	NN	I-NP	O
;	;	:	O	O
amiodarone	amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
;	;	:	O	O
Zocor	Zocor	NNP	B-NP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
;	;	:	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Lasix	Lasix	NNP	B-NP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Multivitamin	Multivitamin	NN	B-NP	O
;	;	:	O	O
calcium	calcium	NN	B-NP	O
carbonate	carbonate	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
in	in	IN	B-PP	O
in-law	in-law	JJ	B-NP	O
apartment	apartment	NN	I-NP	O
with	with	IN	B-PP	O
family	family	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
or	or	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Notable	Notable	NNP	B-NP	O
for	for	IN	B-PP	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
does	do	VBZ	B-VP	O
report	report	VB	I-VP	O
a	a	DT	B-NP	O
viral	viral	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
1	1	CD	I-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
new	new	JJ	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
reports	report	VBZ	B-VP	O
she	she	PRP	B-NP	O
last	last	RB	B-ADVP	O
felt	feel	VBD	B-VP	O
well	well	RB	B-NP	O
1	1	CD	I-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Physical	Physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
T-Max	T-Max	NN	B-NP	B-protein
97.1	97.1	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
68	68	CD	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
95	95	CD	I-NP	O
to	to	TO	B-PP	O
122/61	122/61	CD	B-NP	O
to	to	TO	B-PP	O
83	83	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
.	.	.	O	O

O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
94	94	CD	B-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
sitting	sit	VBG	B-VP	O
upright	upright	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
virtually	virtually	RB	B-VP	O
speaking	speak	VBG	I-VP	O
in	in	IN	B-PP	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
.	.	.	O	O

Mucous	Mucous	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
moist	moist	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
at	at	IN	B-PP	O
the	the	DT	B-NP	O
earlobes	earlobe	NNS	I-NP	O
18	18	CD	B-NP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
.	.	.	O	O

Rhonchi	Rhonchi	NNP	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
base	base	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
irregularly	irregularly	RB	I-NP	O
irregular	irregular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
,	,	,	O	O
dry	dry	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

DP	DP	NN	B-NP	O
,	,	,	O	O
PT	PT	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
+	+	SYM	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Skin	Skin	NNP	B-NP	O
was	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
,	,	,	O	O
dry	dry	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
rashes	rash	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	B-protein
x	x	NN	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
II	II	CD	B-NP	O
through	through	IN	B-PP	O
XII	XII	CD	B-NP	B-DNA
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

Moving	Move	VBG	B-VP	O
all	all	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Admission	Admission	NN	B-NP	O
labs	lab	NNS	I-NP	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
2.1	2.1	CD	B-NP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
to	to	TO	B-PP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

Potassium	Potassium	NN	B-NP	O
4.7	4.7	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
2.7	2.7	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
7.47	7.47	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
46.3	46.3	CD	I-NP	I-protein
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
37	37	CD	I-NP	O
to	to	TO	B-PP	O
39	39	CD	B-NP	O
.	.	.	O	O

First	First	JJ	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
365	365	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
of	of	IN	B-PP	O
3.3	3.3	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
nonspecific	nonspecific	JJ	B-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
paced	paced	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
83-year-old	83-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
AFib	AFib	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
permanent	permanent	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
with	with	IN	B-PP	O
recent	recent	JJ	B-NP	O
conversion	conversion	NN	I-NP	O
into	into	IN	B-PP	O
AFib	AFib	NN	B-NP	O
1	1	CD	I-NP	O
week	week	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
beta-blocker	beta-blocker	NN	B-NP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
,	,	,	O	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

Telemetry	Telemetry	NN	B-NP	O
also	also	RB	B-ADVP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	O
concerning	concerning	NN	I-NP	O
for	for	IN	B-PP	O
ongoing	ongoing	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
last	last	JJ	B-NP	O
examined	examine	VBN	B-VP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
converted	convert	VBD	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
oral	oral	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
for	for	IN	B-PP	O
improved	improve	VBN	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
held	hold	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
restarted	restart	VBD	B-VP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
echo	echo	NN	I-NP	O
on	on	IN	B-PP	O
7/25	7/25	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
akinetic	akinetic	JJ	I-NP	O
septal	septal	JJ	I-NP	O
and	and	CC	I-NP	O
inferior	inferior	JJ	I-NP	O
wall	wall	NN	I-NP	O
;	;	:	O	O
hypokinetic	hypokinetic	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
lateral	lateral	JJ	I-NP	O
and	and	CC	I-NP	O
posterior	posterior	JJ	I-NP	O
wall	wall	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
left	left	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

Aortic	Aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
gradient	gradient	NN	I-NP	O
of	of	IN	B-PP	O
17	17	CD	B-NP	O
and	and	CC	O	O
mean	mean	NN	B-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
AF	AF	NN	I-NP	O
,	,	,	O	O
MR	MR	NN	B-NP	B-protein
,	,	,	O	O
TR	TR	NN	B-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
AP	AP	NN	I-NP	O
of	of	IN	B-PP	O
29	29	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
prior	prior	JJ	I-NP	O
study	study	NN	I-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
.	.	.	O	O

Ischemia	Ischemia	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
ongoing	ongoing	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
were	be	VBD	B-VP	O
concerned	concern	VBN	I-VP	O
for	for	IN	B-PP	O
ongoing	ongoing	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
enzymes	enzyme	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-NP	O
x	x	NN	I-NP	O
3	3	CD	I-NP	O
with	with	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
,	,	,	O	O
stretching	stretch	VBG	B-VP	O
20	20	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
beats	beat	NNS	I-NP	O
,	,	,	O	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
ongoing	ongoing	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
on	on	IN	B-PP	O
5/25	5/25	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
main	main	JJ	I-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
stenosed	stenose	VBN	B-VP	O
and	and	CC	O	O
LAD	LAD	NN	B-NP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
stenosed	stenose	VBN	B-VP	O
,	,	,	O	O
circumflex	circumflex	NN	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
stenosed	stenose	VBN	B-VP	O
,	,	,	O	O
RCA	RCA	NN	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
stenosed	stenose	VBN	B-VP	O
,	,	,	O	O
large	large	JJ	B-NP	O
one	one	CD	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
stenosed	stenose	VBN	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
intact	intact	JJ	I-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
graft	graft	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
an	an	DT	B-NP	O
intact	intact	JJ	I-NP	O
SVT	SVT	NN	I-NP	O
to	to	TO	B-PP	O
OM	OM	NN	B-NP	O
graft	graft	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
underwent	undergo	VBD	B-VP	O
Rotablator	Rotablator	NN	B-NP	O
and	and	CC	I-NP	O
balloon	balloon	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
OM	OM	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
left	left	JJ	B-NP	O
circumflex	circumflex	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
OM	OM	NN	B-NP	O
were	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
beta-blocker	beta-blocker	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
statin	statin	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Plavix	Plavix	NNP	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
remain	remain	VB	I-VP	O
on	on	IN	B-PP	O
Plavix	Plavix	NN	B-NP	O
until	until	IN	B-PP	O
further	further	JJ	B-NP	O
notice	notice	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
baseline	baseline	NN	B-NP	O
AFib	AFib	NN	I-NP	O
with	with	IN	B-PP	O
runs	run	NNS	B-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
improved	improve	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
revascularization	revascularization	NN	I-NP	O
.	.	.	O	O

Rate	Rate	NN	B-NP	O
control	control	NN	I-NP	O
was	be	VBD	B-VP	O
improved	improve	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
beta-blocker	beta-blocker	NN	B-NP	O
and	and	CC	I-NP	O
amiodarone	amiodarone	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

PULMONARY	PULMONARY	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
oxygenated	oxygenate	VBN	B-VP	O
well	well	RB	B-ADVP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
carefully	carefully	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
dye	dye	NN	I-NP	O
load	load	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
oxygenating	oxygenate	VBG	I-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
Hematocrit	Hematocrit	NN	B-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
to	to	TO	I-VP	O
proceed	proceed	VB	I-VP	O
with	with	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	O
followup	followup	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
mild	mild	JJ	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
.	.	.	O	O

PCP	PCP	NN	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
.	.	.	O	O

ENDOCRINE	ENDOCRINE	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
her	her	PRP	B-NP	O
Lantus	Lantus	NNP	I-NP	O
dose	dose	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
suboptimal	suboptimal	JJ	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Hemoglobin	Hemoglobin	NN	B-NP	B-protein
A1c	A1c	NN	I-NP	O
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
6	6	CD	B-NP	O
,	,	,	O	O
indicative	indicative	JJ	B-ADJP	O
of	of	IN	B-PP	O
good	good	JJ	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
current	current	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Levoxyl	Levoxyl	NN	B-NP	O
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
to	to	TO	B-PP	O
1.6	1.6	CD	B-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
forward	forward	JJ	I-NP	O
flow	flow	NN	I-NP	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

Currently	Currently	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
started	start	VBN	I-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-PP	O
cardiac	cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
receive	receive	VB	I-VP	O
bicarb	bicarb	NN	B-NP	O
and	and	CC	I-NP	O
Mucomyst	Mucomyst	NN	I-NP	O
to	to	TO	B-VP	O
aid	aid	VB	I-VP	O
in	in	IN	B-PP	O
renal	renal	JJ	B-NP	O
protection	protection	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
p.m.	p.m.	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
food-restricted	food-restricted	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
,	,	,	O	O
OPHTHO	OPHTHO	NN	B-NP	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
blurry	blurry	NN	I-NP	O
vision	vision	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
neurology	neurology	NN	B-NP	O
and	and	CC	I-NP	O
ophthalmology	ophthalmology	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
corneal	corneal	JJ	I-NP	O
abrasion	abrasion	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
imaging	imaging	NN	I-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
one	one	PRP	B-NP	O
may	may	MD	B-VP	O
consider	consider	VB	I-VP	O
carotid	carotid	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
evaluate	evaluate	VB	I-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
amiodarone	amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
337.5	337.5	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
,	,	,	O	O
Levoxyl	Levoxyl	NNP	B-NP	O
100	100	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Multivitamin	Multivitamin	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
tab	tab	NN	I-NP	I-protein
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Caltrate	Caltrate	NN	B-NP	O
Plus	Plus	NN	I-NP	O
D	D	NN	I-NP	O
1	1	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
30	30	CD	I-NP	O
units	unit	NNS	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
180	180	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
Patient	Patient	NNP	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
,	,	,	O	O
Dr	Dr	NNP	B-NP	O
Gehler	Gehler	NNP	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
1/27/06	1/27/06	CD	B-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
INR	INR	NNP	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
4/10	4/10	CD	B-NP	O
and	and	CC	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
Dr	Dr	NNP	B-NP	O
Downs	Downs	NNP	I-NP	O
Patient	Patient	NNP	I-NP	O
has	have	VBZ	B-VP	O
home	home	NN	B-NP	O
VNA	VNA	NN	I-NP	O
for	for	IN	B-PP	O
BP	BP	NN	B-NP	O
checks	check	NNS	I-NP	O
and	and	CC	O	O
volume	volume	NN	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Any	Any	DT	B-NP	O
questions	question	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
directed	direct	VBN	I-VP	O
at	at	IN	B-PP	O
Dr	Dr	NNP	B-NP	O
Dedecker	Dedecker	NNP	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
3-6470602	3-6470602	CD	B-NP	O
HF	HF	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
DUNAHOE	DUNAHOE	NNP	B-NP	O
,	,	,	O	O
SHELBY	SHELBY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HOECK	HOECK	NN	B-NP	B-protein
,	,	,	O	O
ANDREA	ANDREA	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1976855	1976855	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
2/3/06	2/3/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/3/06	2/3/06	CD	B-NP	O

